201 related articles for article (PubMed ID: 33380149)
1. Histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Comparison of recent WHO classification published 2017 and classification of Histiocyte Society published 2016.
Král Z; Adam Z; Ježová M; Pour L; Krejčí M
Vnitr Lek; 2020; 66(6):19-27. PubMed ID: 33380149
[TBL] [Abstract][Full Text] [Related]
2. Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society.
Favara BE; Feller AC; Pauli M; Jaffe ES; Weiss LM; Arico M; Bucsky P; Egeler RM; Elinder G; Gadner H; Gresik M; Henter JI; Imashuku S; Janka-Schaub G; Jaffe R; Ladisch S; Nezelof C; Pritchard J
Med Pediatr Oncol; 1997 Sep; 29(3):157-66. PubMed ID: 9212839
[TBL] [Abstract][Full Text] [Related]
3. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.
Emile JF; Abla O; Fraitag S; Horne A; Haroche J; Donadieu J; Requena-Caballero L; Jordan MB; Abdel-Wahab O; Allen CE; Charlotte F; Diamond EL; Egeler RM; Fischer A; Herrera JG; Henter JI; Janku F; Merad M; Picarsic J; Rodriguez-Galindo C; Rollins BJ; Tazi A; Vassallo R; Weiss LM;
Blood; 2016 Jun; 127(22):2672-81. PubMed ID: 26966089
[TBL] [Abstract][Full Text] [Related]
4. Histiocytosis and Neoplasms of Macrophage-Dendritic Cell Lineages: Multimodality Imaging with Emphasis on PET/CT.
Huynh KN; Nguyen BD
Radiographics; 2021; 41(2):576-594. PubMed ID: 33606566
[TBL] [Abstract][Full Text] [Related]
5. The changing landscape of pediatric histiocytoses: Birth, life, and transdifferentiation of pediatric histiocytes.
Auerbach A; Aguilera NS
Semin Diagn Pathol; 2023 Nov; 40(6):420-428. PubMed ID: 37258365
[TBL] [Abstract][Full Text] [Related]
6. Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1.
Gatalica Z; Bilalovic N; Palazzo JP; Bender RP; Swensen J; Millis SZ; Vranic S; Von Hoff D; Arceci RJ
Oncotarget; 2015 Aug; 6(23):19819-25. PubMed ID: 26110571
[TBL] [Abstract][Full Text] [Related]
7. Malignant Histiocytosis Comprises a Phenotypic Spectrum That Parallels the Lineage Differentiation of Monocytes, Macrophages, Dendritic Cells, and Langerhans Cells.
Ravindran A; Dasari S; Ruan GJ; Artymiuk CJ; He R; Viswanatha DS; Abeykoon JP; Zanwar S; Young JR; Goyal G; Go RS; Rech KL;
Mod Pathol; 2023 Oct; 36(10):100268. PubMed ID: 37406859
[TBL] [Abstract][Full Text] [Related]
8. MAP2K1-driven mixed Langerhans cell histiocytosis, Rosai-Dorfman-Destombes disease and Erdheim-Chester disease, clonally related to acute myeloid leukemia.
Bonometti A; Ferrario G; Parafioriti A; Giardino D; Simonetti F; Ginori A; Passoni E; Berti E;
J Cutan Pathol; 2021 May; 48(5):637-643. PubMed ID: 33188581
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D1 Expression and Molecular Genetic Findings in Periocular Histiocytoses and Neoplasms of Macrophage-Dendritic Cell Lineage.
Milman T; Eiger-Moscovich M; Henry RK; Ida CM; Ruben M; Shields CL; Lally SE; Penne RB; Stefanyszyn MA; Bilyk JR; Rapuano CJ; Rabinowitz M; Eagle RC
Am J Ophthalmol; 2022 Oct; 242():36-51. PubMed ID: 35594918
[TBL] [Abstract][Full Text] [Related]
10. PU.1 is a useful nuclear marker to distinguish between histiocytosis and histiocyte-rich tumours.
Ungureanu IA; Cohen-Aubart F; Héritier S; Haroche J; Donadieu J; Emile JF
Histopathology; 2023 Aug; 83(2):320-325. PubMed ID: 37012662
[TBL] [Abstract][Full Text] [Related]
11. [Histiocytoses: General classification and molecular criteria].
Emile JF; Charlotte F; Chassagne-Clement C; Copin MC; Fraitag S; Mokhtari K; Moreau A
Presse Med; 2017 Jan; 46(1):46-54. PubMed ID: 26952138
[TBL] [Abstract][Full Text] [Related]
12. Pathological consequence of misguided dendritic cell differentiation in histiocytic diseases.
Berres ML; Allen CE; Merad M
Adv Immunol; 2013; 120():127-61. PubMed ID: 24070383
[TBL] [Abstract][Full Text] [Related]
13. Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Destombes-Rosai-Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders.
Papo M; Cohen-Aubart F; Trefond L; Bauvois A; Amoura Z; Emile JF; Haroche J
Curr Oncol Rep; 2019 May; 21(7):62. PubMed ID: 31115724
[TBL] [Abstract][Full Text] [Related]
14. Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma.
Massoth LR; Hung YP; Ferry JA; Hasserjian RP; Nardi V; Nielsen GP; Sadigh S; Venkataraman V; Selig M; Friedmann AM; Samore W; Killian JK; Milante R; Giessinger J; Foley-Peres K; Marcus C; Severson E; Duncan D; Sivakumar S; Ross JS; Desphande V; Ramkissoon SH; Vergilio JA; Louissaint A; Zukerberg LR; Williams EA
Oncologist; 2021 Jul; 26(7):e1263-e1272. PubMed ID: 33904632
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Langerhans Cell Histiocytosis and Histiocytic Disorders: A Focus on MAPK Pathway Inhibitors.
Geerlinks AV; Abla O
Paediatr Drugs; 2023 Jul; 25(4):399-409. PubMed ID: 37204611
[TBL] [Abstract][Full Text] [Related]
16. [Histiocytic diseases in childhood and adolescence].
Vokuhl C; Oschlies I; Klapper W; Leuschner I
Pathologe; 2015 Sep; 36(5):443-50. PubMed ID: 26292932
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous histiocytoses in children.
Fraitag S; Emile JF
Histopathology; 2022 Jan; 80(1):196-215. PubMed ID: 34958507
[TBL] [Abstract][Full Text] [Related]
18. The histiocytoses: clinical presentation and differential diagnosis.
Gonzalez CL; Jaffe ES
Oncology (Williston Park); 1990 Nov; 4(11):47-60; discussion 60, 62. PubMed ID: 2150325
[TBL] [Abstract][Full Text] [Related]
19. [Cladribine is highly effective in the treatment of Langerhans cell histiocytosis and rare histiocytic disorders of the juvenile xanthogranuloma group].
Adam Z; Szturz P; Pour L; Krejčí M; Zahradová L; Tomíška M; Král Z; Koukalová R; Rehák Z; Mayer J
Vnitr Lek; 2012 Jun; 58(6):455-65. PubMed ID: 22913238
[TBL] [Abstract][Full Text] [Related]
20. [Erdheim-Chester disease and Rosai-Dorfman disease: Pathological, radiological and clinical features of adult non-Langerhans cell histiocytosis].
Bösmüller H; Nann D; Horger M; Fend F
Pathologe; 2015 Sep; 36(5):458-66. PubMed ID: 26305142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
